Cargando…

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis

Acute kidney injury (AKI) is a prevalent pathological condition that is characterized by a precipitous decline in renal function. In recent years, a growing body of studies have demonstrated that renal maladaptation following AKI results in chronic kidney disease (CKD). Therefore, targeting the tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Runzhi, Duan, Jiayu, Pan, Shaokang, Cheng, Fei, Qiao, Yingjin, Feng, Qi, Liu, Dongwei, Liu, Zhangsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344918/
https://www.ncbi.nlm.nih.gov/pubmed/37443140
http://dx.doi.org/10.1038/s41419-023-05969-9
_version_ 1785072968201666560
author Guo, Runzhi
Duan, Jiayu
Pan, Shaokang
Cheng, Fei
Qiao, Yingjin
Feng, Qi
Liu, Dongwei
Liu, Zhangsuo
author_facet Guo, Runzhi
Duan, Jiayu
Pan, Shaokang
Cheng, Fei
Qiao, Yingjin
Feng, Qi
Liu, Dongwei
Liu, Zhangsuo
author_sort Guo, Runzhi
collection PubMed
description Acute kidney injury (AKI) is a prevalent pathological condition that is characterized by a precipitous decline in renal function. In recent years, a growing body of studies have demonstrated that renal maladaptation following AKI results in chronic kidney disease (CKD). Therefore, targeting the transition of AKI to CKD displays excellent therapeutic potential. However, the mechanism of AKI to CKD is mediated by multifactor, and there is still a lack of effective treatments. Ferroptosis, a novel nonapoptotic form of cell death, is believed to have a role in the AKI to CKD progression. In this study, we retrospectively examined the history and characteristics of ferroptosis, summarized ferroptosis’s research progress in AKI and CKD, and discussed how ferroptosis participates in regulating the pathological mechanism in the progression of AKI to CKD. Furthermore, we highlighted the limitations of present research and projected the future evolution of ferroptosis. We hope this work will provide clues for further studies of ferroptosis in AKI to CKD and contribute to the study of effective therapeutic targets to prevent the progression of kidney diseases. [Image: see text]
format Online
Article
Text
id pubmed-10344918
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103449182023-07-15 The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis Guo, Runzhi Duan, Jiayu Pan, Shaokang Cheng, Fei Qiao, Yingjin Feng, Qi Liu, Dongwei Liu, Zhangsuo Cell Death Dis Review Article Acute kidney injury (AKI) is a prevalent pathological condition that is characterized by a precipitous decline in renal function. In recent years, a growing body of studies have demonstrated that renal maladaptation following AKI results in chronic kidney disease (CKD). Therefore, targeting the transition of AKI to CKD displays excellent therapeutic potential. However, the mechanism of AKI to CKD is mediated by multifactor, and there is still a lack of effective treatments. Ferroptosis, a novel nonapoptotic form of cell death, is believed to have a role in the AKI to CKD progression. In this study, we retrospectively examined the history and characteristics of ferroptosis, summarized ferroptosis’s research progress in AKI and CKD, and discussed how ferroptosis participates in regulating the pathological mechanism in the progression of AKI to CKD. Furthermore, we highlighted the limitations of present research and projected the future evolution of ferroptosis. We hope this work will provide clues for further studies of ferroptosis in AKI to CKD and contribute to the study of effective therapeutic targets to prevent the progression of kidney diseases. [Image: see text] Nature Publishing Group UK 2023-07-13 /pmc/articles/PMC10344918/ /pubmed/37443140 http://dx.doi.org/10.1038/s41419-023-05969-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Guo, Runzhi
Duan, Jiayu
Pan, Shaokang
Cheng, Fei
Qiao, Yingjin
Feng, Qi
Liu, Dongwei
Liu, Zhangsuo
The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
title The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
title_full The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
title_fullStr The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
title_full_unstemmed The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
title_short The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
title_sort road from aki to ckd: molecular mechanisms and therapeutic targets of ferroptosis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344918/
https://www.ncbi.nlm.nih.gov/pubmed/37443140
http://dx.doi.org/10.1038/s41419-023-05969-9
work_keys_str_mv AT guorunzhi theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT duanjiayu theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT panshaokang theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT chengfei theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT qiaoyingjin theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT fengqi theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT liudongwei theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT liuzhangsuo theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT guorunzhi roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT duanjiayu roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT panshaokang roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT chengfei roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT qiaoyingjin roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT fengqi roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT liudongwei roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis
AT liuzhangsuo roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis